Addus HomeCare falls on revenue miss despite earnings beat
Addus HomeCare (ADUS) reported Q3 earnings of $1.83 per share, beating estimates by $0.04, but revenue of $387.7M missed expectations. Revenue grew 7% YoY, and adjusted EBITDA rose 13.5%. The company plans to acquire AccentCare's personal care division for $275M, expecting $280M in annualized revenue. Shares fell 2.6% in after-hours trading.
How this was made
The 30-second read
Why it matters
The mixed earnings and acquisition news led to a 2.6% after‑hours decline, reflecting investor focus on revenue miss over EPS beat.
Market read
First‑report earnings and acquisition news provide fresh data for traders; short‑term downside risk but potential medium‑term upside from the acquisition.
What to watch
The $275 M AccentCare personal‑care acquisition adds ~19% revenue, potentially offsetting the near‑term miss.
Background
Addus HomeCare reported Q3 2026 results, beating EPS expectations but missing revenue estimates, and announced a $275 M acquisition of AccentCare's personal‑care division.
Ticker impact
Q3 earnings beat EPS but missed revenue, shares fell 2.6% in after‑hours trading.
likely pressure as investors price in the revenue shortfall.
The earnings release is the first report of the miss; the miss is material relative to expectations and triggered an immediate price decline.
Market effects
Home‑care services sector may see broader scrutiny of revenue growth forecasts.
U.S. small‑cap healthcare stocks could face modest sell pressure.
Limited to U.S. healthcare investors; no global ripple.
Counterpoint
The EPS beat and acquisition could support a longer‑term upside despite the short‑term dip.
Key entities
- companyAddus HomeCare Corporation
NASDAQ‑listed home‑care services provider.
- companyAccentCare
Provider of personal‑care services being acquired.
